{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T06:17:27Z","timestamp":1774678647393,"version":"3.50.1"},"reference-count":54,"publisher":"Pharmaceutical Society of Japan","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,3,25]]},"DOI":"10.1248\/bpb.b25-00445","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T22:11:08Z","timestamp":1774390268000},"page":"525-537","source":"Crossref","is-referenced-by-count":0,"title":["&lt;i&gt;N&lt;\/i&gt;, &lt;i&gt;N\u2032&lt;\/i&gt;-Dicyclohexyl-&lt;i&gt;N&lt;\/i&gt;-linoleic Acylurea, an Unsaturated Fatty Acid Derivative Alleviates Experimental Autoimmune Encephalomyelitis in C57BL\/6 Mice"],"prefix":"10.1248","volume":"49","author":[{"given":"Tingting","family":"Zhang","sequence":"first","affiliation":[{"name":"Medical College, Guangxi University, Nanning 530004, China"},{"name":"School of Pharmacy, Xinyang Agriculture and Forestry University, Xinyang 464000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirui","family":"Mo","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Youjiang Medical University for Nationalities, Baise 533000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongcheng","family":"Luo","sequence":"additional","affiliation":[{"name":"Affiliated Hospital, Youjiang Medical University for Nationalities, Baise 533000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangbin","family":"Ye","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Youjiang Medical University for Nationalities, Baise 533000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Natural Product Chemistry, School of Pharmaceutical Sciences, Guangxi Medical University, Nanning 530021, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minli","family":"Jiang","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Youjiang Medical University for Nationalities, Baise 533000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingkai","family":"Wang","sequence":"additional","affiliation":[{"name":"Medical College, Guangxi University, Nanning 530004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Bi","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Xinyang Agriculture and Forestry University, Xinyang 464000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengmian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Fujian Maternity and Child Health Hospital, Fuzhou 350001, China"},{"name":"College of Clinical Medicine for Obstetrics &amp; Gynecology and Pediatrics, Fujian Medical University, Fuzhou 350001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongquan","family":"Qi","sequence":"additional","affiliation":[{"name":"Medical College, Guangxi University, Nanning 530004, China"},{"name":"Fujian Maternity and Child Health Hospital, Fuzhou 350001, China"},{"name":"College of Clinical Medicine for Obstetrics &amp; Gynecology and Pediatrics, Fujian Medical University, Fuzhou 350001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Dobson R, Giovannoni G. Multiple sclerosis\u2014a review. <i>Eur. J. Neurol.<\/i>, <b>26<\/b>, 27\u201340 (2019).","DOI":"10.1111\/ene.13819"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Rosenkranz T, Novas M, Terborg C. PML in a patient with lymphocytopenia treated with dimethyl fumarate. <i>N. Engl. J. Med.<\/i>, <b>372<\/b>, 1476\u20131478 (2015).","DOI":"10.1056\/NEJMc1415408"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Bloomgren G, Richman S, Hotermans C, Subramanyam M, Goelz S, Natarajan A, Lee S, Plavina T, Scanlon JV, Sandrock A, Bozic C. Risk of natalizumab-associated progressive multifocal leukoencephalopathy. <i>N. Engl. J. Med.<\/i>, <b>366<\/b>, 1870\u20131880 (2012).","DOI":"10.1056\/NEJMoa1107829"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Ho PR, Koendgen H, Campbell N, Haddock B, Richman S, Chang I. Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies. <i>Lancet Neurol.<\/i>, <b>16<\/b>, 925\u2013933 (2017).","DOI":"10.1016\/S1474-4422(17)30282-X"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Sellebjerg F, Barnes D, Filippini G, Midgard R, Montalban X, Rieckmann P, Selmaj K, Visser LH, S\u00f8rensen PS. EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses. <i>Eur. J. Neurol.<\/i>, <b>12<\/b>, 939\u2013946 (2005).","DOI":"10.1111\/j.1468-1331.2005.01352.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Franchin G, Diamond B. Pulse steroids: how much is enough? <i>Autoimmun. Rev.<\/i>, <b>5<\/b>, 111\u2013113 (2006).","DOI":"10.1016\/j.autrev.2005.08.003"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Huscher D, Thiele K, Gromnica-Ihle E, Hein G, Demary W, Dreher R, Zink A, Buttgereit F. Dose-related patterns of glucocorticoid-induced side effects. <i>Ann. Rheum. Dis.<\/i>, <b>68<\/b>, 1119\u20131124 (2009).","DOI":"10.1136\/ard.2008.092163"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Vitturi BK, Cellerino M, Boccia D, Leray E, Correale J, Dobson R, van der Mei I, Fujihara K, Inglese M. Environmental risk factors for multiple sclerosis: a comprehensive systematic review and meta-analysis. <i>J. Neurol.<\/i>, <b>272<\/b>, 513 (2025).","DOI":"10.1007\/s00415-025-13248-0"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Correale J, Gait\u00e1n MI, Ysrraelit MC, Fiol MP. Progressive multiple sclerosis: from pathogenic mechanisms to treatment. <i>Brain<\/i>, <b>140<\/b>, 527\u2013546 (2017).","DOI":"10.1093\/brain\/aww258"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Dendrou CA, Fugger L, Friese MA. Immunopathology of multiple sclerosis. <i>Nat. Rev. Immunol.<\/i>, <b>15<\/b>, 545\u2013558 (2015).","DOI":"10.1038\/nri3871"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Amoriello R, Memo C, Ballerini L, Ballerini C. The brain cytokine orchestra in multiple sclerosis: from neuroinflammation to synaptopathology. <i>Mol. Brain<\/i>, <b>17<\/b>, 4 (2024).","DOI":"10.1186\/s13041-024-01077-7"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Klotz L, Antel J, Kuhlmann T. Inflammation in multiple sclerosis: consequences for remyelination and disease progression. <i>Nat. Rev. Neurol.<\/i>, <b>19<\/b>, 305\u2013320 (2023).","DOI":"10.1038\/s41582-023-00801-6"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) das Neves SP, Sousa JC, Sousa N, Cerqueira JJ, Marques F. Altered astrocytic function in experimental neuroinflammation and multiple sclerosis. <i>Glia<\/i>, <b>69<\/b>, 1341\u20131368 (2021).","DOI":"10.1002\/glia.23940"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Zelic M, Pontarelli F, Woodworth L, Zhu C, Mahan A, Ren Y, LaMorte M, Gruber R, Keane A, Loring P, Guo L, Xia TH, Zhang B, Orning P, Lien E, Degterev A, Hammond T, Ofengeim D. RIPK1 activation mediates neuroinflammation and disease progression in multiple sclerosis. <i>Cell Rep.<\/i>, <b>35<\/b>, 109112 (2021).","DOI":"10.1016\/j.celrep.2021.109112"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Jing X, Yao Y, Wu D, Hong H, Feng X, Xu N, Liu Y, Liang H. IFP35 family proteins promote neuroinflammation and multiple sclerosis. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>32<\/b>, e2102642118 (2021).","DOI":"10.1073\/pnas.2102642118"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Bjelobaba I, Begovic-Kupresanin V, Pekovic S, Lavrnja I. Animal models of multiple sclerosis: focus on experimental autoimmune encephalomyelitis. <i>J. Neurosci. Res.<\/i>, <b>96<\/b>, 1021\u20131042 (2018).","DOI":"10.1002\/jnr.24224"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Constantinescu CS, Farooqi N, O\u2019Brien K, Gran B. Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). <i>Br. J. Pharmacol.<\/i>, <b>164<\/b>, 1079\u20131106 (2011).","DOI":"10.1111\/j.1476-5381.2011.01302.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Takahashi H, Okuda S, Tamura M, Kamei S, Aizawa R, Kobayashi T. Prophylactic treatment with intravenous immunoglobulin attenuates experimental optic neuritis in mice. <i>Biol. Pharm. Bull.<\/i>, <b>42<\/b>, 173\u2013178 (2019).","DOI":"10.1248\/bpb.b18-00458"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Fan Z, Cai L, Wang Y, Zhu Q, Wang S, Chen B. The acidic fraction of Isatidis Radix regulates inflammatory response in LPS-stimulated RAW264.7 macrophages through MAPKs and NF-\u03baB pathway. <i>Evid. Based Complement. Alternat. Med.<\/i>, <b>2021<\/b>, 8879862 (2021).","DOI":"10.1155\/2021\/8879862"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Ruan D, Liu W, Shi Y, Tan M, Yang L, Wang Z, Zhou Y, Wang R. Protective effects of aqueous extract of <i>Radix Isatidis<\/i> on lipopolysaccharide-induced sepsis in C57BL\/6J mice. <i>J. Med. Food<\/i>, <b>1<\/b>, 79\u201389 (2020).","DOI":"10.1089\/jmf.2019.4476"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Shin EK, Kim DH, Lim H, Shin HK, Kim JK. The anti-inflammatory effects of a methanolic extract from <i>Radix Isatidis<\/i> in murine macrophages and mice. <i>Inflammation<\/i>, <b>33<\/b>, 110\u2013118 (2010).","DOI":"10.1007\/s10753-009-9164-9"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Xu H, He L, Chen J, Hou X, Fan F, Wu H, Zhu H, Guo Y. Different types of effective fractions from <i>Radix Isatidis<\/i> revealed a multiple-target synergy effect against respiratory syncytial virus through RIG-I and MDA5 signaling pathways, a pilot study to testify the theory of superposition of traditional Chinese medicine efficacy. <i>J. Ethnopharmacol.<\/i>, <b>239<\/b>, 111901 (2019).","DOI":"10.1016\/j.jep.2019.111901"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Qin Q, Ma PF, Kuang XC, Gao MX, Mo DH, Xia S, Jin N, Xia JJ, Qi ZQ, Lin CW. Novel function of <i>N,N<\/i>-bis(2-chloroethyl)docos-13-enamide for reversal of multidrug resistance in tongue cancer. <i>Eur. J. Pharmacol.<\/i>, <b>721<\/b>, 208\u2013214 (2013).","DOI":"10.1016\/j.ejphar.2013.09.033"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) An K, Qin Q, Yu S, Xue M, Wang Z, Lin Q, Ma Y, Yan G, Mo S, Chen Y, Zhang L, Zhong J, Qi Z, Xia J. Combination of <i>N<\/i>, <i>N\u2032<\/i>-dicyclohexyl-<i>N<\/i>-arachidonic acylurea and tacrolimus prolongs cardiac allograft survival in mice. <i>Immunol. Cell Biol.<\/i>, <b>98<\/b>, 382\u2013396 (2020).","DOI":"10.1111\/imcb.12327"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Ma PF, Jiang J, Gao C, Cheng PP, Li JL, Huang X, Lin YY, Li Q, Peng YZ, Cai MC, Shao W, Zhu Q, Han S, Qin Q, Xia JJ, Qi ZQ. Immunosuppressive effect of compound K on islet transplantation in an STZ-induced diabetic mouse model. <i>Diabetes<\/i>, <b>63<\/b>, 3458\u20133469 (2014).","DOI":"10.2337\/db14-0012"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Zhou LQ, Dong MH, Hu ZW, Tang Y, Chu YH, Chen M, Yang S, Chen Z, Wu LJ, Wang W, Qin C, Tian DS. Staged suppression of microglial autophagy facilitates regeneration in CNS demyelination by enhancing the production of linoleic acid. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>120<\/b>, e2209990120 (2023).","DOI":"10.1073\/pnas.2209990120"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Liu Y, Xiao Y, Gao J, Gao J, Li R, Qi Z, Liu X. MSR405: inhibiting neuroinflammation after spinal cord injury in rats. <i>Biomedicines<\/i>, <b>12<\/b>, 614 (2024).","DOI":"10.3390\/biomedicines12030614"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Stromnes IM, Goverman JM. Active induction of experimental allergic encephalomyelitis. <i>Nat. Protoc.<\/i>, <b>1<\/b>, 1810\u20131819 (2006).","DOI":"10.1038\/nprot.2006.285"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Ghareghani M, Ghanbari A, Dokoohaki S, Farhadi N, Hosseini SM, Mohammadi R, Sadeghi H. Methylprednisolone improves lactate metabolism through reduction of elevated serum lactate in rat model of multiple sclerosis. <i>Biomed. Pharmacother.<\/i>, <b>84<\/b>, 1504\u20131509 (2016).","DOI":"10.1016\/j.biopha.2016.11.042"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Wang Z, Zheng G, Li G, Wang M, Ma Z, Li H, Wang XY, Yi H. Methylprednisolone alleviates multiple sclerosis by expanding myeloid-derived suppressor cells <i>via<\/i> glucocorticoid receptor \u03b2 and S100A8\/9 up-regulation. <i>J. Cell. Mol. Med.<\/i>, <b>24<\/b>, 13703\u201313714 (2020).","DOI":"10.1111\/jcmm.15928"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) W\u00fcst S, van den Brandt J, Reichardt HM, L\u00fchder F. Preventive treatment with methylprednisolone paradoxically exacerbates experimental autoimmune encephalomyelitis. <i>Int. J. Endocrinol.<\/i>, <b>2012<\/b>, 417017 (2012).","DOI":"10.1155\/2012\/417017"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Wei ZS, Hong MF, Su QX, Wang XH, Yu QY, Peng ZX, Zhang MX, Jie A, Wang R, Huang YQ. Super-high-dose methylprednisolone does not improve efficacy or induce glucocorticoid resistance in experimental allergic encephalomyelitis. <i>Neuroimmunomodulation<\/i>, <b>18<\/b>, 28\u201336 (2011).","DOI":"10.1159\/000314736"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Jeong GH, Lee H, Chung BY, Bai HW. A new class of hybrid anti-inflammatory agents of silibinin A modified using gamma irradiation. <i>Chem. Pharm. Bull.<\/i>, <b>4<\/b>, 401\u2013411 (2025).","DOI":"10.1248\/cpb.c25-00040"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) An K, Xue MJ, Zhong JY, Yu SN, Lan TS, Qi ZQ, Xia JJ. Arsenic trioxide ameliorates experimental autoimmune encephalomyelitis in C57BL\/6 mice by inducing CD4<sup>+<\/sup> T cell apoptosis. <i>J. Neuroinflammation<\/i>, <b>17<\/b>, 147 (2020).","DOI":"10.1186\/s12974-020-01829-x"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Fang MC, Yu QQ, Ou JH, Lou J, Zhu JH, Lin ZL. The neuroprotective mechanisms of PPAR-\u03b3: inhibition of microglia-mediated neuroinflammation and oxidative stress in a neonatal mouse model of hypoxic-ischemic white matter injury. <i>CNS Neurosci. Ther.<\/i>, <b>30<\/b>, e70081 (2024).","DOI":"10.1111\/cns.70081"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Jin R, Hao J, Yi Y, Yin D, Hua Y, Li X, Bao H, Han X, Egilmez NK, Sauter ER, Li B. Dietary fats high in linoleic acids impair antitumor T-cell responses by inducing E-FABP-mediated mitochondrial dysfunction. <i>Cancer Res.<\/i>, <b>81<\/b>, 5296\u20135310 (2021).","DOI":"10.1158\/0008-5472.CAN-21-0757"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Kim W, Khan NA, McMurray DN, Prior IA, Wang N, Chapkin RS. Regulatory activity of polyunsaturated fatty acids in T-cell signaling. <i>Prog. Lipid Res.<\/i>, <b>49<\/b>, 250\u2013261 (2010).","DOI":"10.1016\/j.plipres.2010.01.002"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Haghikia A, Hohlfeld R, Gold R, Fugger L. Therapies for multiple sclerosis: translational achievements and outstanding needs. <i>Trends Mol. Med.<\/i>, <b>19<\/b>, 309\u2013319 (2013).","DOI":"10.1016\/j.molmed.2013.03.004"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Ochiai T, Nakajima K, Nagata M, Hori S, Asano T, Isono K. Studies of the induction and maintenance of long-term graft acceptance by treatment with FK506 in heterotopic cardiac allotransplantation in rats. <i>Transplantation<\/i>, <b>6<\/b>, 734\u2013738 (1987).","DOI":"10.1097\/00007890-198712000-00002"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Petcher TJ, Weber H, R\u00fcegger A. Crystal and molecular structure of an iodo-derivative of the cyclic undecapeptide cyclosporin A. <i>Helv. Chim. Acta<\/i>, <b>59<\/b>, 1480\u20131489 (1976).","DOI":"10.1002\/hlca.19760590509"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Huwiler A, Zangemeister-Wittke U. The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: Recent findings and new perspectives. <i>Pharmacol. Ther.<\/i>, <b>185<\/b>, 34\u201349 (2018).","DOI":"10.1016\/j.pharmthera.2017.11.001"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Harbige LS, Layward L, Morris-Downes MM, Dumonde DC, Amor S. The protective effects of omega-6 fatty acids in experimental autoimmune encephalomyelitis (EAE) in relation to transforming growth factor-beta 1 (TGF-<i>\u03b2<\/i>1) up-regulation and increased prostaglandin E<sub>2<\/sub> (PGE<sub>2<\/sub>) production. <i>Clin. Exp. Immunol.<\/i>, <b>122<\/b>, 445\u2013452 (2000).","DOI":"10.1046\/j.1365-2249.2000.01399.x"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Voet S, Prinz M, van Loo G. Microglia in central nervous system inflammation and multiple sclerosis pathology. <i>Trends Mol. Med.<\/i>, <b>25<\/b>, 112\u2013123 (2019).","DOI":"10.1016\/j.molmed.2018.11.005"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Healy LM, Stratton JA, Kuhlmann T, Antel J. The role of glial cells in multiple sclerosis disease progression. <i>Nat. Rev. Neurol.<\/i>, <b>18<\/b>, 237\u2013248 (2022).","DOI":"10.1038\/s41582-022-00624-x"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Faissner S, Plemel JR, Gold R, Yong VW. Progressive multiple sclerosis: from pathophysiology to therapeutic strategies. <i>Nat. Rev. Drug Discov.<\/i>, <b>18<\/b>, 905\u2013922 (2019).","DOI":"10.1038\/s41573-019-0035-2"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Absinta M, Maric D, Gharagozloo M, Garton T, Smith MD, Jin J, Fitzgerald KC, Song A, Liu P, Lin JP, Wu T, Johnson KR, McGavern DB, Schafer DP, Calabresi PA, Reich DS. A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis. <i>Nature<\/i>, <b>597<\/b>, 709\u2013714 (2021).","DOI":"10.1038\/s41586-021-03892-7"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Krakowski M, Owens T. Interferon-\u03b3 confers resistance to experimental allergic encephalomyelitis. <i>Eur. J. Immunol.<\/i>, <b>26<\/b>, 1641\u20131646 (1996).","DOI":"10.1002\/eji.1830260735"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Skurkovich S, Boiko A, Beliaeva I, Buglak A, Alekseeva T, Smirnova N, Kulakova O, Tchechonin V, Gurova O, Deomina T, Favorova OO, Skurkovic B, Gusev E. Randomized study of antibodies to IFN-gamma and TNF-alpha in secondary progressive multiple sclerosis. <i>Mult. Scler.<\/i>, <b>7<\/b>, 277\u2013284 (2001).","DOI":"10.1177\/135245850100700502"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Arellano G, Ottum PA, Reyes LI, Burgos PI, Naves R. Stage-specific role of interferon-\u03b3 in experimental autoimmune encephalomyelitis and multiple sclerosis. <i>Front. Immunol.<\/i>, <b>6<\/b>, 492 (2015).","DOI":"10.3389\/fimmu.2015.00492"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Naves R, Singh SP, Cashman KS, Rowse AL, Axtell RC, Steinman L, Mountz JD, Steele C, De Sarno P, Raman C. The interdependent, overlapping, and differential roles of type I and II IFNs in the pathogenesis of experimental autoimmune encephalomyelitis. <i>J. Immunol.<\/i>, <b>191<\/b>, 2967\u20132977 (2013).","DOI":"10.4049\/jimmunol.1300419"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) He D, Liu L, Shen D, Zou P, Cui L. The effect of peripheral immune cell counts on the risk of multiple sclerosis: a mendelian randomization study. <i>Front. Immunol.<\/i>, <b>13<\/b>, 867693 (2022).","DOI":"10.3389\/fimmu.2022.867693"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Col\u00f3n Ortiz C, Eroglu C. Astrocyte signaling and interactions in Multiple Sclerosis. <i>Curr. Opin. Cell Biol.<\/i>, <b>86<\/b>, 102307 (2024).","DOI":"10.1016\/j.ceb.2023.102307"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Hemmer B, Kerschensteiner M, Korn T. Role of the innate and adaptive immune responses in the course of multiple sclerosis. <i>Lancet Neurol.<\/i>, <b>14<\/b>, 406\u2013419 (2015).","DOI":"10.1016\/S1474-4422(14)70305-9"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Van Kaer L, Postoak JL, Wang C, Yang G, Wu L. Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE. <i>Cell. Mol. Immunol.<\/i>, <b>16<\/b>, 531\u2013539 (2019).","DOI":"10.1038\/s41423-019-0221-5"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/3\/49_b25-00445\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T03:22:39Z","timestamp":1774668159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/3\/49_b25-00445\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00445","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"article-number":"b25-00445"}}